FDA Approved: AMNESTEEM — Supplemental Application (Mylan Pharmaceuticals Inc.)

View source ↗

Summary

The FDA approved a supplemental application for AMNESTEEM (isotretinoin) from Mylan Pharmaceuticals, resulting in a label/labeling change for the product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acne Vulgaris

Drugs mentioned

• AMNESTEEM (isotretinoin)

Snippet

SUPPL AP for AMNESTEEM (ISOTRETINOIN)